Article
The Effects of Regulatory Neglect on Health Care Consumers
Testimony of David Balto Before the Senate Committee on Commerce, Science and Transportation
CAP Action Senior Fellow David Balto testifies before the Subcommittee of the Senate Committee on Commerce, Science and Transportation.
Media Contact
Government Affairs
CAP Action Senior Fellow David Balto testifies before the Subcommittee of the Senate Committee on Commerce, Science and Transportation. Read the full testimony.
Chairman Pryor, Ranking Member Wicker and other members of the committee, I appreciate the opportunity to come before you today and testify about health care competition and consumer protection enforcement. As a former antitrust enforcement official, I strongly believe the mission of the Federal Trade Commission and Antitrust Division of the Department of Justice is vital to protecting consumers and competition. However, in the past administration, the priorities of those enforcement agencies were not effectively aligned with the critical priorities in the health care market, with the result that there is substantial anticompetitive and fraudulent activity that raises prices and costs for consumers and the American taxpayer, especially conduct by certain health care intermediaries—Health Insurers, Pharmacy Benefit Managers, or PBMs, and Group Purchasing Organizations, or GPOs.
Read the full testimony. (CAP Action)
The positions of American Progress, and our policy experts, are independent, and the findings and conclusions presented are those of American Progress alone. A full list of supporters is available here. American Progress would like to acknowledge the many generous supporters who make our work possible.